LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2012

Jul 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-06-22

Reporting Person: Hemmeter Molly (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-22	Common Stock	M	12500	—	Acquired	12500	Direct
2012-06-22	Common Stock	M	4585	—	Disposed	7915	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-22	Restricted Stock Awards	$7.68	M	12500	Disposed	2012-06-22	Common Stock (12500)	Direct

Footnotes

F1: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis.

F2: The restricted stock units vested on June 22, 2012

F3: Ms Hemmeter surrendered to the Issuer the right to receive an aggregate of 4,585 shares of Common Stock. Ms. Hemmeter did not sell any shares of Common Stock in connection with the foregoing exercise.